BCAX
Bicara Therapeutics Inc.
$16.25
-$0.21(-1.28%)
53
Overall
60
Value
66
Tech
34
Quality
Market Cap
$932.48M
Volume
538.59K
52W Range
$7.80 - $28.09
Target Price
$32.14
Key Metrics Overview
| Market Cap | $932.48M | P/E Ratio | N/A |
| 52W High | $28.09 | 52W Low | $7.80 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | N/A | 52W Position | 41.6% |
| Overall Score | 53 | Value Score | 60 |
| Quality Score | 34 | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $-2.32 | EPS Next Est | $-2.71 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAX | $16.25 | -1.3% | 538.59K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicara Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW